Application 125249

Type
BLA
Sponsor
REGENERON PHARMACEUTICALS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ARCALYSTRILONACEPTVIAL; SINGLE-USE220MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
61755-001ArcalystrilonaceptRegeneron Pharmaceuticals, Inc.BLACurrent
61755-001ArcalystrilonaceptRegeneron Pharmaceuticals, Inc.BLACurrent
61755-001ArcalystrilonaceptRegeneron Pharmaceuticals, Inc.BLACurrent
61755-001ArcalystrilonaceptRegeneron Pharmaceuticals, Inc.BLACurrent
61755-001ArcalystrilonaceptRegeneron Pharmaceuticals, Inc.BLACurrent
73604-914ArcalystrilonaceptKiniksa Pharmaceuticals (UK), Ltd.BLACurrent
73604-914ArcalystrilonaceptKiniksa Pharmaceuticals (UK), Ltd.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85335SUPPL 2026-03-12
85334SUPPL 2026-03-12
81541SUPPL 2025-03-12
66823SUPPL2021-03-22
66812SUPPL2021-03-19
65672SUPPL2020-12-22
65628SUPPL2020-12-21
64097SUPPL2020-07-27
64090SUPPL2020-07-24
43311ORIG2008-05-02
31869ORIG2008-04-09
39876ORIG2008-03-11